Review Article
Pharmacological Strategies to Prevent Contrast-Induced Acute Kidney Injury
Table 5
Prospective, randomized clinical trials comparing efficacy of vitamin C with placebo and other agents for contrast-induced AKI after angiography prophylaxis.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
value of *ascorbic acid and **NAC compared to placebo group. bid: twice daily; CAG: coronary angiography; CI-AKI: contrast-induced acute kidney injury; Cr: creatinine; g: gram; h: hour; IONICM: isoosmolarity nonionic contrast media; IV: intravenous; kg: kilogram body weight; LONICM: low osmolarity nonionic contrast media; kg: kilogram body weight; mg: milligram; mL: milliliter; NAC: N-acetylcysteine; ND: no data; NSS: normal saline solution; N/2: 0.45% NaCl; po: per oral route; q12h: every 12 hours; RRT: renal replacement therapy. |